secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001367644-24-000125
Event type: other
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions grants 15,000 RSUs to EVP Jennifer Fox for strategic contributions
--------------------------------------------------------------------------------

- Jennifer Fox, EVP External Affairs, General Counsel, and Corporate Secretary, receives 15,000 restricted stock units.
- Award vests on first anniversary of grant date, contingent on continued employment.
- Special one-time discretionary award approved by Compensation Committee on July 11, 2024.
- Award recognizes Fox's substantial contributions to executing recent strategic initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000125/0001367644-24-000125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000125/ebs-20240711.htm
  HTML page:      https://secwatch.observer/filing/0001367644-24-000125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer